期刊文献+

叶酸偶联紫杉醇纳米粒的制备及其生物效应研究 被引量:1

Preparation and Biological Effect of Folic Acid Coupling Paclitaxel Nanoparticles
下载PDF
导出
摘要 目的以叶酸修饰的生物可降解材料乳酸-羟基乙酸共聚物(PLGA-PEG-FA)为载体,构建叶酸偶联紫杉醇纳米粒〔PLGA-PEG-FA(PTX)-NPs〕并进行评价。研究其对MCF-7细胞的效应并初步探讨其靶向作用机制。方法乳化分散法制备PLGA-PEG-FA(PTX)-NPs,并对纳米粒的形态、粒径、Zeta电位、包封率及载药量进行评价;同法制备无叶酸偶联的紫杉醇纳米粒〔PLGA-PEG(PTX)-NPs〕,分别用荧光物质FITC标记,应用荧光显微镜观察其对MCF-7细胞和A549细胞的靶向作用,以及游离叶酸对PLGA-PEG-FA(PTX)-NPs的干扰作用;MTT法观察PLGA-PEG-FA(PTX)-NPs、PLGA-PEG(PTX)-NPs对MCF-7细胞的生长抑制作用;流式细胞术检测细胞凋亡率。结果制备的PLGA-PEG-FA(PTX)-NPs为均匀球形粒子,粒径为(88.2±6.7)nm,Zeta电位为(56.5±4.2)mV,包封率为(92.96±0.16)%,载药量为(4.84±0.10)%。与PLGA-PEG(PTX)-NPs相比,PLGA-PEG-FA(PTX)-NPs能更有效的被MCF-7细胞吞噬(P<0.05);PLGA-PEG-FA(PTX)-NPs、PLGA-PEG(PTX)-NPs对A549细胞无明显靶向作用;培养基中加入游离叶酸干扰了PLGA-PEG-FA(PTX)-NPs的靶向性。MTT法测得PLGA-PEG-FA(PTX)-NPs抑制MCF-7细胞生长的IC50值(10.72μg·ml^(-1))明显低于PLGAPEG(PTX)-NPs组(17.41μg·ml^(-1),P<0.05),紫杉醇浓度在1~15μg·ml^(-1)时,PLGA-PEG-FA(PTX)-NPs组的生长抑制率在24h明显高于PLGA-PEG(PTX)-NPs组(P<0.05),紫杉醇浓度达到20μg·ml^(-1)时,两组无显著性差异。PLGA-PEG(PTX)-NPs组的48h细胞凋亡率(87.04%)明显高于PLGA-PEG(PTX)-NPs组(64.14%)。结论制备的PLGA-PEG-FA(PTX)-NPs能够靶向抑制MCF-7细胞增殖并促进其凋亡,其靶向性可能是由叶酸受体介导的。 Objective To establish and evaluate the folic acid coupling paclitaxel nanoparticles〔PLGA-PEG-FA(PTX)-NPs〕with biodegradable materials of lactic acid-glycolic acid copolymer modified by FA(PLGA-PEG-FA)as the carrier,and to study the effect and mechanism of PLGA-PEG-FA(PTX)-NPs in targeting treatment of MCF-7cells.Methods The emulsification-dispersion method was used to prepare PLGA-PEG-FA(PTX)-NPs,which were evaluated in terms of the morphology of nanoparticles,particle size,zeta potential,entrapment efficiency and drug-loading rate.The same method was used to prepare paclitaxel nanoparticles without FA 〔PLGA-PEG(PTX)-NPs〕.PLGA-PEG-FA(PTX)-NPs and PLGA-PEG(PTX)-NPs were marked by FITC,and their targeting treatment to MCF-7and A549 was observed with a fluorescence microscope.The interference effect of free folic acid in the cell culture medium to PLGA-PEG(PTX)-NPs was observed with a fluorescence microscope.The growth inhibition was studied by MTT.The apoptosis rate of cells was detected by flow cytometry.Results PLGA-PEG-FA(PTX)-NPs were uniform spherical particle,with a particle size of(88.2±6.7)nm.Zeta potential was(56.5±4.2)mV,the entrapment efficiency was(92.96±0.16)%,and the drug-loading rate was(4.84±0.10)%.Compared to PLGA-PEG(PTX)-NPs,MCF-7cells could devour PLGA-PEG-FA(PTX)-NPs more effectively(P 0.05).PLGAPEG-FA(PTX)-NPs and PLGA-PEG(PTX)-NPs couldn′t be targeted to A549 cells obviously.The IC50ofPLGA-PEG-FA(PTX)-NPs inhibiting MCF-7cells proliferation(10.72μg·ml^(-1))was significantly lower than PLGA-PEG(PTX)-NPs(17.41-1μg·ml)(P 0.05).When the final concentration of paclitaxel of the two types of nanoparticles was 1-15μg·ml^(-1),the growth inhibition rate of MCF-7cells in PLGA-PEGFA(PTX)-NPs group was significantly increased compared to PLGA-PEG(PTX)-NPs after cells were treated for 24h(P 0.05).When the final concentration of paclitaxel reached 20μg·ml^(-1),the cell growth inhibition rate of the two groups had no significant difference(P 0.05).The apoptosis rate of MCF-7cells in PLGA-PEG-FA(PTX)-NPs group(87.04%)was significantly increased compared to PLGA-PEG(PTX)-NPs group(64.14%)after cells were treated for 48h(P 0.05).ConclusionInhibiting MCF-7cells proliferation constructed can be targeted to inhibit MCF-7cell proliferation and promote their apoptosis,and the targeting treatment may be mediated by folate receptors.
作者 胡晓丹 徐荣 袁海龙 吴燕 张福成 HU Xiao-dan XU Rong YUAN Hai-long WU Yan ZHANG Fu-cheng(Department of Pharmacy,General Hospital of Air Force ,Beijing 100142,China)
出处 《解放军药学学报》 CAS CSCD 2016年第6期508-513,共6页 Pharmaceutical Journal of Chinese People's Liberation Army
基金 全军医学科技青年培育项目基金 No.13QNP079
关键词 紫杉醇 纳米粒 叶酸 MCF-7细胞 靶向性 paclitaxel nanoparticles folate MCF-7 cells targeting treatment
  • 相关文献

参考文献4

二级参考文献47

  • 1陆伟跃.叶酸介导广谱肿瘤靶向研究[J].生物物理学报,2009,0(S1):65-65. 被引量:2
  • 2魏昌华,姚春芳,恽榴红.新型抗癌药──紫杉醇[J].中国药学杂志,1996,31(5):259-263. 被引量:57
  • 3林凤云,朱照静.叶酸受体介导的靶向给药研究进展[J].国外医学(药学分册),2006,33(3):178-181. 被引量:8
  • 4李媛,李振宇.天然抗癌药物—紫杉醇[J].中山大学研究生学刊(自然科学与医学版),2006,27(4):58-62. 被引量:24
  • 5Salazar MD,Ratnam M.The folate receptor:what does it promise in tisaue-targeted therapeutics?[J].Cancer Metost Rev,2007,26(1):141-152.
  • 6Pinhassi RI,Assaraf YG,Farber S,et al.Arabinogalactanfolie acid-drug conjugate for targeted delivery and targetactivated release of anticancer drugs to folate receptoroverexpressing cells[J].Biomacromolecules,2010,11(1):294-303.
  • 7Wacheck V,Zangemeister-Wittke U.Antisense molecules for targeted cancer therapy[J].Crit Rev Oncol Hematol,2006,59(1):65-73.
  • 8Low PS,Kularatne SA.Folate-targeted therapeutic and imaging agents for cancer[J].Curr Opin Chem Biol,2009,13(3):256-262.
  • 9Venugopal J,Prahhakaran MP,Low PS,et al.Nanotechnology for nanomedicine and delivery of drugs[J].Curr Pharm Des,2008,14(22):2184-2200.
  • 10Lines MG.Nanomateriuls for practical functional uses[J].J Alloy Compd,2008,449(1/2):242-245.

共引文献11

同被引文献8

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部